% Options for packages loaded elsewhere
\PassOptionsToPackage{unicode}{hyperref}
\PassOptionsToPackage{hyphens}{url}
%
\documentclass[
]{article}
\usepackage{lmodern}
\usepackage{amssymb,amsmath}
\usepackage{ifxetex,ifluatex}
\ifnum 0\ifxetex 1\fi\ifluatex 1\fi=0 % if pdftex
  \usepackage[T1]{fontenc}
  \usepackage[utf8]{inputenc}
  \usepackage{textcomp} % provide euro and other symbols
\else % if luatex or xetex
  \usepackage{unicode-math}
  \defaultfontfeatures{Scale=MatchLowercase}
  \defaultfontfeatures[\rmfamily]{Ligatures=TeX,Scale=1}
\fi
% Use upquote if available, for straight quotes in verbatim environments
\IfFileExists{upquote.sty}{\usepackage{upquote}}{}
\IfFileExists{microtype.sty}{% use microtype if available
  \usepackage[]{microtype}
  \UseMicrotypeSet[protrusion]{basicmath} % disable protrusion for tt fonts
}{}
\makeatletter
\@ifundefined{KOMAClassName}{% if non-KOMA class
  \IfFileExists{parskip.sty}{%
    \usepackage{parskip}
  }{% else
    \setlength{\parindent}{0pt}
    \setlength{\parskip}{6pt plus 2pt minus 1pt}}
}{% if KOMA class
  \KOMAoptions{parskip=half}}
\makeatother
\usepackage{xcolor}
\IfFileExists{xurl.sty}{\usepackage{xurl}}{} % add URL line breaks if available
\IfFileExists{bookmark.sty}{\usepackage{bookmark}}{\usepackage{hyperref}}
\hypersetup{
  pdftitle={Cost-Effectiveness and Decision Modeling in R},
  pdfauthor={The DARTH workgroup},
  hidelinks,
  pdfcreator={LaTeX via pandoc}}
\urlstyle{same} % disable monospaced font for URLs
\usepackage[margin=1in]{geometry}
\usepackage{longtable,booktabs}
% Correct order of tables after \paragraph or \subparagraph
\usepackage{etoolbox}
\makeatletter
\patchcmd\longtable{\par}{\if@noskipsec\mbox{}\fi\par}{}{}
\makeatother
% Allow footnotes in longtable head/foot
\IfFileExists{footnotehyper.sty}{\usepackage{footnotehyper}}{\usepackage{footnote}}
\makesavenoteenv{longtable}
\usepackage{graphicx,grffile}
\makeatletter
\def\maxwidth{\ifdim\Gin@nat@width>\linewidth\linewidth\else\Gin@nat@width\fi}
\def\maxheight{\ifdim\Gin@nat@height>\textheight\textheight\else\Gin@nat@height\fi}
\makeatother
% Scale images if necessary, so that they will not overflow the page
% margins by default, and it is still possible to overwrite the defaults
% using explicit options in \includegraphics[width, height, ...]{}
\setkeys{Gin}{width=\maxwidth,height=\maxheight,keepaspectratio}
% Set default figure placement to htbp
\makeatletter
\def\fps@figure{htbp}
\makeatother
\setlength{\emergencystretch}{3em} % prevent overfull lines
\providecommand{\tightlist}{%
  \setlength{\itemsep}{0pt}\setlength{\parskip}{0pt}}
\setcounter{secnumdepth}{-\maxdimen} % remove section numbering

\title{Cost-Effectiveness and Decision Modeling in R}
\usepackage{etoolbox}
\makeatletter
\providecommand{\subtitle}[1]{% add subtitle to \maketitle
  \apptocmd{\@title}{\par {\large #1 \par}}{}{}
}
\makeatother
\subtitle{Decision Tree Exercise}
\author{The DARTH workgroup}
\date{}

\begin{document}
\maketitle

Developed by the Decision Analysis in R for Technologies in Health
(DARTH) workgroup:

Fernando Alarid-Escudero, PhD (1)

Eva A. Enns, MS, PhD (2)

M.G. Myriam Hunink, MD, PhD (3,4)

Hawre J. Jalal, MD, PhD (5)

Eline M. Krijkamp, MSc (3)

Petros Pechlivanoglou, PhD (6,7)

Alan Yang, MSc (7)

In collaboration of:

\begin{enumerate}
\def\labelenumi{\arabic{enumi}.}
\tightlist
\item
  Drug Policy Program, Center for Research and Teaching in Economics
  (CIDE) - CONACyT, Aguascalientes, Mexico
\item
  University of Minnesota School of Public Health, Minneapolis, MN, USA
\item
  Erasmus MC, Rotterdam, The Netherlands
\item
  Harvard T.H. Chan School of Public Health, Boston, USA
\item
  University of Pittsburgh Graduate School of Public Health, Pittsburgh,
  PA, USA
\item
  University of Toronto, Toronto ON, Canada
\item
  The Hospital for Sick Children, Toronto ON, Canada
\end{enumerate}

Please cite our publications when using this code:

\begin{itemize}
\item
  Jalal H, Pechlivanoglou P, Krijkamp E, Alarid-Escudero F, Enns E,
  Hunink MG. An Overview of R in Health Decision Sciences. Med Decis
  Making. 2017; 37(3): 735-746.
  \url{https://journals.sagepub.com/doi/abs/10.1177/0272989X16686559}
\item
  Krijkamp EM, Alarid-Escudero F, Enns EA, Jalal HJ, Hunink MGM,
  Pechlivanoglou P. Microsimulation modeling for health decision
  sciences using R: A tutorial. Med Decis Making. 2018;38(3):400--22.
  \url{https://journals.sagepub.com/doi/abs/10.1177/0272989X18754513}
\item
  Krijkamp EM, Alarid-Escudero F, Enns E, Pechlivanoglou P, Hunink MM,
  Jalal H. A Multidimensional Array Representation of State-Transition
  Model Dynamics. Med Decis Making. 2020 Online first.
  \url{https://doi.org/10.1177/0272989X19893973}
\end{itemize}

Copyright 2017, THE HOSPITAL FOR SICK CHILDREN AND THE COLLABORATING
INSTITUTIONS. All rights reserved in Canada, the United States and
worldwide. Copyright, trademarks, trade names and any and all associated
intellectual property are exclusively owned by THE HOSPITAL FOR Sick
CHILDREN and the collaborating institutions. These materials may be
used, reproduced, modified, distributed and adapted with proper
attribution.

\hypertarget{exercise-i-treatment-for-viral-encephalitis-a-decision-tree}{%
\section{Exercise I: Treatment for Viral encephalitis -- A Decision
Tree}\label{exercise-i-treatment-for-viral-encephalitis-a-decision-tree}}

Viral encephalitis can be caused by herpes viruses (HVE) or other
viruses (OVE). Herpes viruses cause approximately 52\% of cases of viral
encephalitis. Without treatment, the risk of complications (death or
severe sequelae) for HVE is 71\%; for OVE, the risk is only 1\%. A drug,
vidarabine, decreases the likelihood of complications due to HVE from
71\% down to 36\%. However, among OVE patients, treatment with
vidarabine is associated with severe side effects, increasing the risk
of complications from the 1\% baseline to 20\%. It is possible to obtain
a definitive diagnosis of HVE by means of a brain biopsy, but the
procedure itself also has a 5\% probability of inducing complications.

You are tasked with evaluating the healthcare costs and benefits
associated with three possible management strategies (no treatment,
vidarabine treatment, or brain biopsy followed by vidarabine treatment
for those who are diagnosed with HVE). Benefits will be measured in
terms of quality-adjusted life-years (QALYs).

The healthcare cost of a case of viral encephalitis without
complications is \$1,200; however, if complications occur, the cost
rises to \$9,000. The cost of vidarabine treatment is \$9,500, while a
brain biopsy is a \$25,000 procedure.

A patient who recovers from viral encephalitis without complications has
an average of 20 remaining QALYs; however, a patient who experiences
complications has an average of 19 remaining QALYs. Since a brain biopsy
is an unpleasant procedure, patients who undergo it also experience a
one-time loss of 0.01 QALYs regardless of the outcome of the biopsy.

Parameters are summarized in Table 1. Use the code template provided in
``HVE\_DecisitionTree\_Template.Rmd'' as a starting point for this
exercise.

\hypertarget{tasks}{%
\subsection{Tasks}\label{tasks}}

\begin{enumerate}
\def\labelenumi{\arabic{enumi}.}
\item
  Sketch out the decision tree, with a particular focus on the outcome
  values (costs and QALYs) at terminal nodes.
\item
  The code template contains calculations for the ``No Treatment''
  strategy. Write code that calculates the expected outcomes for the two
  other strategies.
\item
  Use the \texttt{calculate\_icers()} function from the \texttt{dampack}
  package to calculate the incremental costs, QALYs, and ICERs of each
  strategy. Type ``\texttt{?calculate\_icers()}'' to see function
  documentation.
\end{enumerate}

\textbf{Table I: Input parameters}

\begin{longtable}[]{@{}llc@{}}
\toprule
\begin{minipage}[b]{0.45\columnwidth}\raggedright
\textbf{Parameter}\strut
\end{minipage} & \begin{minipage}[b]{0.23\columnwidth}\raggedright
\textbf{R name}\strut
\end{minipage} & \begin{minipage}[b]{0.23\columnwidth}\centering
\textbf{Value}\strut
\end{minipage}\tabularnewline
\midrule
\endhead
\begin{minipage}[t]{0.45\columnwidth}\raggedright
Prevalence of HVE\strut
\end{minipage} & \begin{minipage}[t]{0.23\columnwidth}\raggedright
\texttt{p\_HVE}\strut
\end{minipage} & \begin{minipage}[t]{0.23\columnwidth}\centering
0.52\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.45\columnwidth}\raggedright
Probability of complications (death or sequelae) without treatment\strut
\end{minipage} & \begin{minipage}[t]{0.23\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.23\columnwidth}\centering
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.45\columnwidth}\raggedright
- HVE\strut
\end{minipage} & \begin{minipage}[t]{0.23\columnwidth}\raggedright
\texttt{p\_HVE\_comp}\strut
\end{minipage} & \begin{minipage}[t]{0.23\columnwidth}\centering
0.71\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.45\columnwidth}\raggedright
- OVE\strut
\end{minipage} & \begin{minipage}[t]{0.23\columnwidth}\raggedright
\texttt{p\_OVE\_comp}\strut
\end{minipage} & \begin{minipage}[t]{0.23\columnwidth}\centering
0.01\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.45\columnwidth}\raggedright
Probability of complications (death or sequelae) with vidarabine
treatment\strut
\end{minipage} & \begin{minipage}[t]{0.23\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.23\columnwidth}\centering
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.45\columnwidth}\raggedright
- HVE\strut
\end{minipage} & \begin{minipage}[t]{0.23\columnwidth}\raggedright
\texttt{p\_HVE\_comp\_tx}\strut
\end{minipage} & \begin{minipage}[t]{0.23\columnwidth}\centering
0.36\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.45\columnwidth}\raggedright
- OVE\strut
\end{minipage} & \begin{minipage}[t]{0.23\columnwidth}\raggedright
\texttt{p\_OVE\_comp\_tx}\strut
\end{minipage} & \begin{minipage}[t]{0.23\columnwidth}\centering
0.20\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.45\columnwidth}\raggedright
Probability of complications due to brain biopsy\strut
\end{minipage} & \begin{minipage}[t]{0.23\columnwidth}\raggedright
\texttt{p\_biopsy\_comp}\strut
\end{minipage} & \begin{minipage}[t]{0.23\columnwidth}\centering
0.05\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.45\columnwidth}\raggedright
Quality-adjusted life-years (QALYs)\strut
\end{minipage} & \begin{minipage}[t]{0.23\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.23\columnwidth}\centering
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.45\columnwidth}\raggedright
- Remaining QALYs without VE complications\strut
\end{minipage} & \begin{minipage}[t]{0.23\columnwidth}\raggedright
\texttt{q\_VE}\strut
\end{minipage} & \begin{minipage}[t]{0.23\columnwidth}\centering
20\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.45\columnwidth}\raggedright
- Remaining QALYs with VE complications\strut
\end{minipage} & \begin{minipage}[t]{0.23\columnwidth}\raggedright
\texttt{q\_VE\_comp}\strut
\end{minipage} & \begin{minipage}[t]{0.23\columnwidth}\centering
19\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.45\columnwidth}\raggedright
- QALY loss due to brain biopsy\strut
\end{minipage} & \begin{minipage}[t]{0.23\columnwidth}\raggedright
\texttt{q\_loss\_biopsy}\strut
\end{minipage} & \begin{minipage}[t]{0.23\columnwidth}\centering
-0.01\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.45\columnwidth}\raggedright
Healthcare costs\strut
\end{minipage} & \begin{minipage}[t]{0.23\columnwidth}\raggedright
\strut
\end{minipage} & \begin{minipage}[t]{0.23\columnwidth}\centering
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.45\columnwidth}\raggedright
- Cost of viral encephalitis without complications\strut
\end{minipage} & \begin{minipage}[t]{0.23\columnwidth}\raggedright
\texttt{c\_VE}\strut
\end{minipage} & \begin{minipage}[t]{0.23\columnwidth}\centering
\$1,200\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.45\columnwidth}\raggedright
- Cost of viral encephalitis with complications\strut
\end{minipage} & \begin{minipage}[t]{0.23\columnwidth}\raggedright
\texttt{c\_VE\_comp}\strut
\end{minipage} & \begin{minipage}[t]{0.23\columnwidth}\centering
\$9,000\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.45\columnwidth}\raggedright
- Vidarabine treatment\strut
\end{minipage} & \begin{minipage}[t]{0.23\columnwidth}\raggedright
\texttt{c\_tx}\strut
\end{minipage} & \begin{minipage}[t]{0.23\columnwidth}\centering
\$9,500\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.45\columnwidth}\raggedright
- Brain biopsy\strut
\end{minipage} & \begin{minipage}[t]{0.23\columnwidth}\raggedright
\texttt{c\_biopsy}\strut
\end{minipage} & \begin{minipage}[t]{0.23\columnwidth}\centering
\$25,000\strut
\end{minipage}\tabularnewline
\bottomrule
\end{longtable}

\hypertarget{exercise-ii-probabilistic-sensitivity-analysis-of-the-decision-tree-model}{%
\section{Exercise II: Probabilistic sensitivity analysis of the Decision
Tree
model}\label{exercise-ii-probabilistic-sensitivity-analysis-of-the-decision-tree-model}}

This exercise continues based on the HVE decision tree from Exercise I.
In this exercise, you will do a probabilistic sensitivity analysis (PSA)
with 1000 simulations \texttt{(n\_sim)}. The Table describes the
distributions for the variables you used in the previous exercise.

\hypertarget{tasks-1}{%
\subsection{Tasks}\label{tasks-1}}

\begin{enumerate}
\def\labelenumi{\arabic{enumi}.}
\setcounter{enumi}{3}
\item
  Change some input values and to see if/how the expected outcomes under
  each strategy change (One-way and two-way sensitivity analyses).
\item
  Create the \texttt{calculate\_ce\_out} \texttt{R} function of the
  decision tree model in the file ``Functions\_decision\_tree\_HVE.R''.
\item
  Create a function called \texttt{gen\_psa} to sample values for the
  uncertain parameters using the appropriate distributions. Hint:
  package \texttt{truncnorm} deals with truncated normal distributions.
\item
  Open the file ``decision\_tree\_HVE\_SA\_template.R'' and conduct a
  probabilistic Cost-Effectiveness analysis of treatment vs
  no-treatment.
\item
  Create histograms of model inputs.
\item
  Create a cost-effectiveness plane to present discounted costs and
  QALYs.
\item
  Create the cost-effectiveness acceptability curves (CEAC) and frontier
  (CEAF) for the treatment comparison assuming WTP thresholds of \(\$0\)
  to \(\$300,000\).
\item
  Create the expected loss curves (ELCs) plot
\item
  Create an expected value of perfect information (EVPI) plot.
\end{enumerate}

\textbf{Table II: Input parameters for probabilistic analysis}

\begin{longtable}[]{@{}lrr@{}}
\toprule
\begin{minipage}[b]{0.34\columnwidth}\raggedright
\textbf{Parameter}\strut
\end{minipage} & \begin{minipage}[b]{0.18\columnwidth}\raggedleft
\textbf{Distribution}\strut
\end{minipage} & \begin{minipage}[b]{0.39\columnwidth}\raggedleft
\textbf{Distribution values}\strut
\end{minipage}\tabularnewline
\midrule
\endhead
\begin{minipage}[t]{0.34\columnwidth}\raggedright
Prevalence of HVE\strut
\end{minipage} & \begin{minipage}[t]{0.18\columnwidth}\raggedleft
Beta\strut
\end{minipage} & \begin{minipage}[t]{0.39\columnwidth}\raggedleft
\(\alpha=30, \ \beta=170\)\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.34\columnwidth}\raggedright
Probability of complications (death or sequelae) without treatment\strut
\end{minipage} & \begin{minipage}[t]{0.18\columnwidth}\raggedleft
\strut
\end{minipage} & \begin{minipage}[t]{0.39\columnwidth}\raggedleft
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.34\columnwidth}\raggedright
- HVE\strut
\end{minipage} & \begin{minipage}[t]{0.18\columnwidth}\raggedleft
Beta\strut
\end{minipage} & \begin{minipage}[t]{0.39\columnwidth}\raggedleft
\(\alpha=30, \ \beta=170\)\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.34\columnwidth}\raggedright
- OVE\strut
\end{minipage} & \begin{minipage}[t]{0.18\columnwidth}\raggedleft
Beta\strut
\end{minipage} & \begin{minipage}[t]{0.39\columnwidth}\raggedleft
\(\alpha=30, \ \beta=170\)\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.34\columnwidth}\raggedright
Probability of complications (death or sequelae) with vidarabine
treatment\strut
\end{minipage} & \begin{minipage}[t]{0.18\columnwidth}\raggedleft
\strut
\end{minipage} & \begin{minipage}[t]{0.39\columnwidth}\raggedleft
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.34\columnwidth}\raggedright
- HVE\strut
\end{minipage} & \begin{minipage}[t]{0.18\columnwidth}\raggedleft
Beta\strut
\end{minipage} & \begin{minipage}[t]{0.39\columnwidth}\raggedleft
\(\alpha=30, \ \beta=170\)\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.34\columnwidth}\raggedright
- OVE\strut
\end{minipage} & \begin{minipage}[t]{0.18\columnwidth}\raggedleft
Beta\strut
\end{minipage} & \begin{minipage}[t]{0.39\columnwidth}\raggedleft
\(\alpha=30, \ \beta=170\)\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.34\columnwidth}\raggedright
Probability of complications due to brain biopsy\strut
\end{minipage} & \begin{minipage}[t]{0.18\columnwidth}\raggedleft
Beta\strut
\end{minipage} & \begin{minipage}[t]{0.39\columnwidth}\raggedleft
\(\alpha=30, \ \beta=170\)\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.34\columnwidth}\raggedright
Quality-adjusted life-years (QALYs)\strut
\end{minipage} & \begin{minipage}[t]{0.18\columnwidth}\raggedleft
\strut
\end{minipage} & \begin{minipage}[t]{0.39\columnwidth}\raggedleft
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.34\columnwidth}\raggedright
- Remaining QALYs without VE complications\strut
\end{minipage} & \begin{minipage}[t]{0.18\columnwidth}\raggedleft
Normal\strut
\end{minipage} & \begin{minipage}[t]{0.39\columnwidth}\raggedleft
\(\mu = log(3), \ \sigma = 0.01\)\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.34\columnwidth}\raggedright
- Remaining QALYs with VE complications\strut
\end{minipage} & \begin{minipage}[t]{0.18\columnwidth}\raggedleft
Normal\strut
\end{minipage} & \begin{minipage}[t]{0.39\columnwidth}\raggedleft
\(\mu = log(3), \ \sigma = 0.01\)\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.34\columnwidth}\raggedright
- QALY loss due to brain biopsy\strut
\end{minipage} & \begin{minipage}[t]{0.18\columnwidth}\raggedleft
Tr. Normal\strut
\end{minipage} & \begin{minipage}[t]{0.39\columnwidth}\raggedleft
\(\mu = 1.00, \ \sigma = 0.01, \ b = 1\)\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.34\columnwidth}\raggedright
Healthcare costs\strut
\end{minipage} & \begin{minipage}[t]{0.18\columnwidth}\raggedleft
\strut
\end{minipage} & \begin{minipage}[t]{0.39\columnwidth}\raggedleft
\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.34\columnwidth}\raggedright
- Cost of viral encephalitis without complications\strut
\end{minipage} & \begin{minipage}[t]{0.18\columnwidth}\raggedleft
Gamma\strut
\end{minipage} & \begin{minipage}[t]{0.39\columnwidth}\raggedleft
shape = 100.0, scale = 20.0\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.34\columnwidth}\raggedright
- Cost of viral encephalitis with complications\strut
\end{minipage} & \begin{minipage}[t]{0.18\columnwidth}\raggedleft
Gamma\strut
\end{minipage} & \begin{minipage}[t]{0.39\columnwidth}\raggedleft
shape = 100.0, scale = 20.0\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.34\columnwidth}\raggedright
- Vidarabine treatment\strut
\end{minipage} & \begin{minipage}[t]{0.18\columnwidth}\raggedleft
Gamma\strut
\end{minipage} & \begin{minipage}[t]{0.39\columnwidth}\raggedleft
shape = 100.0, scale = 20.0\strut
\end{minipage}\tabularnewline
\begin{minipage}[t]{0.34\columnwidth}\raggedright
- Brain biopsy\strut
\end{minipage} & \begin{minipage}[t]{0.18\columnwidth}\raggedleft
Gamma\strut
\end{minipage} & \begin{minipage}[t]{0.39\columnwidth}\raggedleft
shape = 100.0, scale = 20.0\strut
\end{minipage}\tabularnewline
\bottomrule
\end{longtable}

\end{document}
